Guangdong Marubi Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 30, 2022 at 04:17 am IST
Share
Guangdong Marubi Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 382.67 million compared to CNY 404.12 million a year ago. Revenue was CNY 382.67 million compared to CNY 404.12 million a year ago. Net income was CNY 65.48 million compared to CNY 100.13 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.25 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.25 a year ago.
Guangdong Marubi Biotechnology Co., Ltd is a China-based company mainly engaged in development and manufacture, design, production and sales of various cosmetics, as well as the provision of related services. The Company's products mainly include eye care products, skin cleansing products, skin care products (cream lotion and mask), make-up products and others. The Company's brands mainly include Maru, Cac and Passional Lover. The Company mainly conducts its businesses in domestic market.